Media Database
>
Katrina Altersitz

Katrina Altersitz

Vice President, Editorial Features/ Contributor at Healio

Contact this person
Email address
k*****@*******.comGet email address
Influence score
53
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

healio.com

‘Do your due diligence’ in cases of suspected, recurrent hepatic encephalopathy

PHILADELPHIA — Hepatologists and gastroenterologists must be internal medicine physicians, not just specialists, to determine the root cause of complaints in patients with suspected hepatic encephalopathy, according to an expert. “People have to remember that not everything a patient complains about in cirrhosis is hepatic encephalopathy. Please do your due diligence,” Jasmohan
healio.com

Identifying, treating alcohol-associated liver disease in women req...

The rate of alcohol-associated liver disease among women is the rise and physicians must keep it in mind when discussing medical history with their female patients, according to a review presented here. The findings were presented as part of the Postgraduate Course at the ACG Annual Meeting.
healio.com

From 300 patients to 1,600, City of Hope remains at the forefront o...

When Healio | Cell Therapy Next visited City of Hope in 2019, the institute boasted a robust cell therapy program, having treated 300 patients with the then-newly approved therapy.Today, City of Hope reports more than 1,600 patients have received cell therapy treatment, and the institution has completed or is conducting more than 80 clinical trials across many cancer types, including 35 in solid
healio.com

Looking back, looking forward: Penn’s CAR-T program continues path ...

In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation, Healio’s Cell Therapy Next staff went onsite to University of Pennsylvania’s newly minted center. In this tour, experts from Penn walked through the manufacturing, patient involvement and clinical trial boon happening in their daily lives.
healio.com

HemOnc Today celebrates the 2024 Disruptive Innovators - Healio

CHICAGO — Healio once again welcomed the excitement of the Disruptive Innovator Awards, working with new partners and celebrating nine distinct areas of progress in oncology and hematology.Hosted again by Shikha Jain, MD, FACP, joined this year by Mark A. Lewis, MD, as the “understudy” to Edward S. Kim, MD, MBA, FACP, FASCO, who had family celebrations, the ceremony followed a
healio.com

'Downstream effects' of alcohol use disorder swell in wake of COVID...

VANCOUVER, British Columbia — With alcohol-related disease still on the rise after surging during the COVID-19 pandemic, an expert here discussed treatment options, including liver transplantation, for patients with alcoholic hepatitis. “You have to realize alcoholic liver disease, especially alcoholic hepatitis, is increasing,” Stanley M. Cohen, MD, FACG, professor of medicine
healio.com

Shift from NAFLD to MASLD does not necessarily require change in .....

VANCOUVER, British Columbia — Despite recent changes in nomenclature for metabolic dysfunction-associated steatotic liver disease, an expert here noted that clinical pathways largely remain the same and require reinforcing. “Fatty liver has changed its name and this is a result of a global process — a multiyear, multisociety process — that included over 50 countries that
healio.com

'Our future is bright': ACG president kicks off annual meeting with...

VANCOUVER, British Columbia — The outgoing ACG president delivered his address at the 2023 Annual Scientific Meeting, highlighting the college’s many achievements and ongoing collegiality, as well as his personal gratitude to colleagues. “I enthusiastically report to you that our college is exciting, energetic, effective and financially sound,” Daniel J. Pambianco, MD,
healio.com

Healio celebrates 2023 Disruptive Innovators at ACG - Healio

VANCOUVER, British Columbia — Healio Gastroenterology and its collaborators unveiled its newest class of Disruptive Innovators Award recipients during the 2023 American College of Gastroenterology Annual Meeting.Each awardee in the nine categories represents the core of gastroenterology or hepatology and has pushed the field continually revolutionize and improve. And, you – our
healio.com

Long-term data needed to determine cost efficacy of new DLBCL ... -...

NEW ORLEANS — Cost efficacy of polatuzumab vedotin added to traditional treatments for diffuse large B-cell lymphoma in the front-line requires long-term PFS data, according to a poster presented at ASH Annual Meeting and Exhibition.“After 2 years of follow up, the pola-R-CHP regimen [polatuzumab vedotin (Polivy, Genentech), rituximab (Rituxan; Genentech, Biogen), cyclophosphamide,
healio.com

Global burden of non-Hodgkin lymphoma estimated to increase 1.5 ......

NEW ORLEANS — Looking at 185 countries, a projection presented at the ASH Annual Meeting and Exhibition suggests the global burden of non-Hodgkin lymphoma will increase by 778,000 cases by 2040.“We saw the growing incident trends in non-Hodgkin lymphoma particularly among the elderly population and the large increase in the incidence may indicate the growing prevalence of risk factors